Data3s today announced it has been selected to provide a major overhaul of Medochemie's data infrastructure that will unify the company's information systems and enable better sharing of information among countries.

Data3s Acquires First Financial Services Client, NWD Private Asset Management, Broadening Focus Beyond Pharma

Data3s, a leading provider of customer relationship management solutions for the life sciences, today announced that the Czech and Slovak offices of Glenmark Pharmaceuticals Ltd. have renewed their contract for another three years.

Data3s, a global provider of pharma-focused CRM software, today announced that Actavis Slovakia has successfully implemented eluzzion CRM, Data3s' flagship product for life science companies, to support their country sales organization.

Data3s today announced that Actavis has selected eluzzion CRM, a leading customer relationship management and business intelligence platform for life sciences companies, to support its Italian sales organization.

Serbian affiliate's decision based on the "Excellent recommendation from our colleagues in the Czech Republic regarding the user friendly characteristics of the system and the high level of user satisfaction."

Spanish generics leader, Actavis Spain SA, signs 3-year contract with Data3s for eluzzion CRM, an advanced customer relationship management software solution for pharmaceutical and life science organizations.

Data3s today announced that Glenmark Pharmaceuticals Sp. z o.o., the Polish division of Glenmark Pharmaceuticals Ltd. (GPL), has signed a 5-year agreement with Data3s for eluzzion CRM

"We're very glad to have such a sophisticated yet cost-effective solution." - HI-LCD a.s.

CEO of STADA Czech Republic Writes in Official Letter of Reference: "I can confidently recommend eluzzion CRM to any company looking for a thorough, dynamic software solution to support their sales force and improve their performance levels."